|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
5U54CA163071-07
|
$1,619,382
|
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143727-09
|
$1,119,110
|
|
PALAFOX, NEAL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-09
|
$714,423
|
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation
|
5R01CA208535-03
|
$506,533
|
|
GROSSHANS, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
|
5R01CA219893-02
|
$427,989
|
|
GHOSH, MOUMITA
|
NATIONAL JEWISH HEALTH
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-03
|
$377,438
|
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
|
5R01CA219880-02
|
$670,182
|
|
PALUCKA, ANNA KAROLINA
|
JACKSON LABORATORY
|
|
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
|
5R01CA220004-02
|
$698,964
|
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
|
5R01CA208735-02
|
$730,063
|
|
FELSHER, DEAN
|
STANFORD UNIVERSITY
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
5R01CA219667-02
|
$523,048
|
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT
|
5R01CA208765-03
|
$343,846
|
|
YANG, QING
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
|
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
|
5R01CA208634-03
|
$560,277
|
|
JURECIC, ROLAND
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment
|
5R01CA217934-02
|
$463,899
|
|
ST CLAIR, DARET
|
UNIVERSITY OF KENTUCKY
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-04
|
$119,807
|
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
5P20CA202923-04
|
$54,305
|
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202920-02
|
$301,538
|
|
MEADE, CATHY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
1/2 The GUIDE Cancer Research Training Project
|
5P20CA202908-04
|
$186,883
|
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156734-08
|
$1,691,502
|
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
5P20CA221697-02
|
$310,904
|
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2-Regional Geohealth Hub Centered in Peru-Peru
|
5U01TW010107-04
|
$224,955
|
|
GONZALES, GUSTAVO
|
UNIVERSIDAD PERUANA CAYETANO HEREDIA
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-09
|
$1,003,901
|
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
5U54CA163068-07
|
$1,751,252
|
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-09
|
$1,192,031
|
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
2/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202922-02
|
$242,408
|
|
MIELE, LUCIO
|
LSU HEALTH SCIENCES CENTER
|
|
2/2 The GUIDE Cancer Research Training Project
|
5P20CA202907-04
|
$204,897
|
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-08
|
$1,870,359
|
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
5P20CA221696-02
|
$222,707
|
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/2, University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143728-09
|
$977,538
|
|
LEON GUERRERO, RACHAEL
|
UNIVERSITY OF GUAM
|
|
2/2-Air Pollution and Health GeoHealth Hub Research and Capacity Building-US
|
5U2RTW010108-04
|
$224,999
|
|
CASH, RICHARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
2/2-Regional Geohealth Hub Centered in Peru-US
|
5U2RTW010114-04
|
$224,871
|
|
STEENLAND, NELSON
|
EMORY UNIVERSITY
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-13
|
$1,101,004
|
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
22nd International AIDS Conference (AIDS 2018), Amsterdam, the Netherlands, 23-27 July 2018
|
1R13AI138840-01
|
$10,000
|
|
BEYRER, CHRISTOPHER
|
IAS
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-13
|
$1,170,535
|
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
??PK mediated melanoma stem cell oncolysis through non-redundant programmed cell
|
1F31CA154087-01
|
$27,540
|
$27,540
|
Colunga, Aric
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
A Biopsychosocial Approach to Behavioral Oncology in Young Adults
|
5F99CA222727-02
|
$32,259
|
|
DARABOS, KATHLEEN
|
HUNTER COLLEGE
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
|
5U01DK108300-04
|
$190,000
|
|
PARK, WALTER
|
STANFORD UNIVERSITY
|
|
A communication-based intervention for advanced cancer patient-caregiver dyads to increase engagement in advance care planning and reduce caregiver burden
|
1R21CA224874-01A1
|
$192,247
|
|
SHEN, MEGAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A DRUGGABLE CHROMATIN MODIFIER PATHWAY IN HCC
|
1R21CA229927-01
|
$218,588
|
|
WAJAPEYEE, NARENDRA
|
YALE UNIVERSITY
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera
|
1R01CA139119-01A2
|
$268,920
|
$268,920
|
Chaudhary, Preet
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Magnetic Bead Assay for Rapid Isolation and Identification of Circulating Tumor Cells
|
1R43CA228917-01
|
$300,000
|
|
LIU, PENG
|
MICROSENSOR LABS, LLC
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
5F32CA210540-02
|
$61,174
|
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath
|
1R21CA229057-01
|
$226,587
|
|
FU, XIAO-AN
|
UNIVERSITY OF LOUISVILLE
|
|
A Mobile-Support Program to Facilitate Nutritional Caregiving in Head and Neck Cancer
|
5R21CA215557-02
|
$162,581
|
|
STERBA, KATHERINE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions
|
1R44CA228897-01
|
$299,244
|
|
HACHEY, DAVID
|
FRONTIER DIAGNOSTICS, LLC
|
|
A National Curriculum in Cancer Genomics for Residents and Medical Students
|
5R25CA168544-07
|
$231,248
|
|
HASPEL, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery
|
5R03CA216127-02
|
$83,750
|
|
YANG, YANG
|
YALE UNIVERSITY
|
|
A novel approach for the selective inhibition of HIF-2a in kidney cancer
|
5R01CA217905-02
|
$336,943
|
|
KOH, MEI YEE
|
UNIVERSITY OF UTAH
|
|
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
|
1R41CA228622-01
|
$298,305
|
|
NGUYEN, HIEN-ANH
|
ENZYME BY DESIGN, INC.
|
Total relevant funding to Herpes - Other for this search: $58,565,922
|